Loading...
Loading...
RPRX| Name | Value |
|---|---|
| Revenues | 573.5M |
| Cost of Revenue | 0.0M |
| Gross Profit | 573.5M |
| Operating Expense | 381.3M |
| Operating I/L | 192.2M |
| Other Income/Expense | 28.2M |
| Interest Income | 14.0M |
| Pretax | 220.4M |
| Income Tax Expense | 2.6M |
| Net Income/Loss | 217.8M |
Royalty Pharma plc is a leading buyer of biopharmaceutical royalties and a key player in funding innovations in the biopharmaceutical industry. The company specializes in identifying, evaluating, and acquiring royalties on various biopharmaceutical therapies. It collaborates with academic institutions, research hospitals, biotechnology companies, and pharmaceutical companies to build a diverse portfolio of royalties on approximately 35 marketed therapies and 10 development-stage product candidates. These therapies address therapeutic areas including rare diseases, cancer, neurology, infectious diseases, hematology, and diabetes.
